Tag: Glioma

Oncotarget News

Figure 2: BCAS1+ cells in diffuse gliomas are morphologically different from BCAS1+ cells in healthy brain tissue.

BCAS1 Defines a Heterogeneous Cell Population in Diffuse Glioma Patients

January 31, 2024

this is the first study describing a BCAS1+ cell population in a large cohort of diffuse glioma patients.”BUFFALO, NY- January 31, 2024 – A new research paper was published in... read more

Figure 1: (A) Canonical STAT3 activation pathway. (B) WP1066 and TTI-101, examples of small molecule STAT3 inhibitors that are cell penetrant.

Oncotarget

STAT3 as a Target in H3K27M-mutant DMGs

October 9, 2023

Children diagnosed with these tumors have [...] a median survival of approximately 12 months.” BUFFALO, NY- October 9, 2023 – A new editorial perspective was published in Oncotarget's Volume 14 on... read more

Oncotarget

Behind the Study: Extending Survival in Glioma Models

May 10, 2021

Behind the Study is a series of transcribed videos from researchers elaborating on their recent oncology-focused studies published by Oncotarget. A new Behind the Study is released each... read more

Oncotarget

Behind the Study: Critical Role STAT3 Plays in Glioma-initiating Cells

February 8, 2021

The head chair of pathology and a graduate research assistant from the University of Tennessee Health Science Center detail their paper published in Oncotarget titled, "The critical role that STAT3... read more